{"id":"W3139163066","doi":"10.1200/jco.20.02619","title":"Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Placebo; Internal medicine; Adverse effect; Myelodysplastic syndromes; Anemia; Gastroenterology; Clinical endpoint; International Prognostic Scoring System; Azacitidine; Interim analysis; Randomized controlled trial; Surgery; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009316729,0.001344735,0.002461046,0.0003911373,0.000477372,0.0007016072,0.0006230432,0.001272335,0.005085849],"category_scores_gemma":[0.00112885,0.000469445,0.0009404836,0.0003559741,0.0009018398,0.0004686851,0.0002304933,0.002142662,0.0006263601],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005514667,"about_ca_system_score_gemma":0.000914941,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009117529,"about_ca_topic_score_gemma":0.00233567,"domain_scores_codex":[0.9996866,0.0001522142,0.00002172436,0.00006055043,0.00002868364,0.00005026053],"domain_scores_gemma":[0.999414,0.0001355729,0.0001644904,0.0000376345,0.00004237559,0.0002059297],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9600721,0.006992186,0.001322694,0.0006630564,0.0006366239,0.00006363371,0.00004519499,0.000393485,0.008239425,0.0001136089,0.001066901,0.02039114],"study_design_scores_gemma":[0.9506406,0.04607463,0.00174088,0.00002249728,0.0002121792,0.00003728727,0.00001099233,0.0002619766,0.0004538601,0.00006533799,0.0004727227,0.000007001088],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9846786,0.00652512,0.0005064458,0.0005981266,0.0004346857,0.004334586,0.001040883,0.0001283041,0.001753201],"genre_scores_gemma":[0.9861873,0.003201605,0.00133419,0.001040193,0.0004511425,0.004780305,0.00100649,0.00001600873,0.001982802],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005085849,"threshold_uncertainty_score":0.01701391,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05024886019407585,"score_gpt":0.4222112638362222,"score_spread":0.3719624036421463,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}